Your browser doesn't support javascript.
loading
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast Cancer.
Batalini, Felipe; Xiong, Niya; Tayob, Nabihah; Polak, Madeline; Eismann, Julia; Cantley, Lewis C; Shapiro, Geoffrey I; Adalsteinsson, Viktor; Winer, Eric P; Konstantinopoulos, Panagiotis A; D'Andrea, Alan; Swisher, Elizabeth M; Matulonis, Ursula A; Wulf, Gerburg M; Mayer, Erica L.
Affiliation
  • Batalini F; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Xiong N; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Tayob N; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Polak M; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Eismann J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Cantley LC; Department of Obstetrics and Gynecology, University Medical Center Freiburg, Freiburg, Germany.
  • Shapiro GI; Department of Oncology, Weill Medical College of Cornell University, New York, New York.
  • Adalsteinsson V; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Winer EP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Konstantinopoulos PA; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.
  • D'Andrea A; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Swisher EM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Matulonis UA; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
  • Wulf GM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Mayer EL; Department of Medicine, Harvard Medical School, Boston, Massachusetts.
Clin Cancer Res ; 28(8): 1493-1499, 2022 04 14.
Article in En | MEDLINE | ID: mdl-35149538
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Combined Chemotherapy Protocols / Triple Negative Breast Neoplasms Type of study: Clinical_trials Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2022 Document type: Article Country of publication: